🔗 Share this article

This year's prestigious award in medical science has been granted for transformative findings that illuminate how the body's defense network targets harmful pathogens while protecting the healthy tissues.

Three esteemed scientists—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this honor.

Their work identified unique "sentinels" within the defense system that eliminate malfunctioning immune cells that could attacking the body.

The discoveries are now enabling innovative therapies for immune disorders and malignancies.

These winners will divide a monetary award worth 11m SEK.

Crucial Findings

"The research has been essential for comprehending how the immune system operates and the reason we don't all suffer from severe self-attack conditions," stated the chair of the award panel.

This trio's research explain a fundamental mystery: In what way does the immune system defend us from numerous infections while keeping our healthy cells intact?

Our body's protection system employs immune cells that search for signs of disease, even pathogens and bacteria it has not met before.

Such cells utilize detectors—called recognition units—that are generated by chance in countless variations.

This provides the immune system the capacity to fight a wide array of invaders, but the randomness of the mechanism inevitably produces immune cells that may attack the body.

Protectors of the Immune System

Researchers previously understood that a portion of these problematic defense cells were destroyed in the thymus—the site where immune cells develop.

This year's Nobel Prize honors the discovery of T-reg cells—known as the body's "peacekeepers"—which patrol the system to neutralize other defenders that assault the healthy cells.

It is known that this process fails in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.

A Nobel panel stated, "These discoveries have laid the foundation for a novel area of investigation and spurred the creation of new treatments, for example for tumors and immune disorders."

In malignancies, T-regs block the system from attacking the growth, so studies are aimed at reducing their numbers.

In autoimmune diseases, experiments are exploring boosting T-reg cells so the organism is no longer being harmed. A comparable method could also be effective in reducing the risks of organ transplant rejection.

Innovative Experiments

Professor Shimon Sakaguchi, from a Japanese institution, conducted experiments on rodents that had their thymus extracted, causing self-attack conditions.

The researcher showed that introducing immune cells from healthy animals could stop the illness—implying there was a system for blocking immune cells from attacking the body.

Mary Brunkow, from the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in mice and people that resulted in the identification of a genetic factor vital for how regulatory T-cells operate.

"Their pioneering work has revealed how the immune system is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," commented a prominent biological science specialist.

"This research is a striking illustration of how fundamental physiological research can have far-reaching implications for human health."